CLAIRIGENE

CLAIRIgene, LLC was founded in 2019 as a spinout from Duke University to address the genetic causes of neurodegenerative diseases. Its primary technology is based on a research collaboration between Drs. Ornit Chiba-Falek and Boris Kantor. Dr. Chiba-Falek is Division Chief of Translational Brain Sciences at Duke University. Her research attempts to better understand the genetic processes underpinning age-related neurodegenerative diseases, in particular AD and Lewy body spectrum diseases. Dr. Kantor of the Duke University Viral Vector Core specializes in development of virus mediated tools for gene transfer... Founded by innovative scientists with decades of experience, CLAIRIgene is committed to rapidly advancing our therapeutics to the clinic. Our team has witnessed first-hand the turbulent journey those with dementia experience. Driven by science and inspired by dementia community, our team continues their dedication bring drugs to patients and work towards a better tomorrow for..

Also known as: CLAIRIgene, LLC

Primary location: Durham United States